Reversible inhibition of lysine specific demethylase 1 is a novel anti-tumor strategy for poorly differentiated endometrial carcinomaEmily R. Theisen(University of Utah), Margit M. Janát‐Amsbury(University of Utah)BMC CancerOctober 9, 201410.1186/1471-2407-14-752Cited by 50SaveCiteExport RISWatch citationsRelated PapersTranscriptomic analysis functionally maps the intrinsically disordered domain of EWS/FLI and reveals novel transcriptional dependencies for oncogenesis|Genes & Cancer|2019|30